Education
About Us
Working with TipRanks
Follow Us
Kingworld Medicines Group Ltd. (HK:1110)
:1110
RESEARCH TOOLSreports
Total Valuation
Kingworld Medicines Group Ltd. has a market cap or net worth of HK$357.83M. The enterprise value is HK$503.89M.
Market CapHK$357.83M
Enterprise ValueHK$503.89M
Share Statistics
Kingworld Medicines Group Ltd. has 622,499,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding622,499,940
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kingworld Medicines Group Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 6.18%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)6.18%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee1.09M
Profits Per Employee42.75K
Employee Count972
Asset Turnover0.75
Inventory Turnover6.58
Valuation Ratios
The current PE Ratio of Kingworld Medicines Group Ltd. is 5.92. Kingworld Medicines Group Ltd.’s PEG ratio is -0.70.
PE Ratio5.92
PS Ratio0.00
PB Ratio0.74
Price to Fair Value0.38
Price to FCF4.86
Price to Operating Cash Flow2.44
PEG Ratio-0.70
Income Statement
In the last 12 months, Kingworld Medicines Group Ltd. had revenue of 1.06B and earned 41.56M in profits. Earnings per share was 0.07.
Revenue1.06B
Gross Profit270.45M
Operating Income89.70M
Pretax Income95.52M
Net Income41.56M
EBITDA100.46M
Earnings Per Share (EPS)0.07
Cash Flow
In the last 12 months, operating cash flow was 163.36M and capital expenditures -54.92M, giving a free cash flow of 108.44M billion.
Operating Cash Flow163.36M
Free Cash Flow108.44M
Free Cash Flow per Share0.17
Dividends & Yields
Kingworld Medicines Group Ltd. pays an annual dividend of HK$0.031, resulting in a dividend yield of 5.66%
Dividend Per ShareHK$0.031
Dividend Yield5.66%
Payout Ratio40.79%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.20
52-Week Price Change7.27%
50-Day Moving Average0.52
200-Day Moving Average0.46
Relative Strength Index (RSI)61.42
Average Volume (3m)819.87K
Important Dates
Kingworld Medicines Group Ltd. upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMar 28, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJun 05, 2025
Financial Position
Kingworld Medicines Group Ltd. as a current ratio of 1.18, with Debt / Equity ratio of 47.22%
Current Ratio1.18
Quick Ratio0.95
Debt to Market Cap1.57
Net Debt to EBITDA1.66
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Kingworld Medicines Group Ltd. has paid 21.05M in taxes.
Income Tax21.05M
Effective Tax Rate0.22
Enterprise Valuation
Kingworld Medicines Group Ltd. EV to EBITDA ratio is 4.11, with an EV/FCF ratio of 0.00.
EV to Sales0.39
EV to EBITDA4.11
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Kingworld Medicines Group Ltd. has HK$249.60M in cash and marketable securities with ¥402.44M in debt, giving a net cash position of HK$152.84M billion.
Cash & Marketable SecuritiesHK$249.60M
Total Debt¥402.44M
Net CashHK$152.84M
Net Cash Per ShareHK$0.25
Tangible Book Value Per ShareHK$1.07
Margins
Gross margin is 28.99%, with operating margin of 8.45%, and net profit margin of 3.92%.
Gross Margin28.99%
Operating Margin8.45%
Pretax Margin9.00%
Net Profit Margin3.92%
EBITDA Margin9.47%
EBIT Margin8.54%
Analyst Forecast
The average price target for Kingworld Medicines Group Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-3.59%
EPS Growth Forecast4.81%